Luminex Corporation (LMNX)
NASDAQ: LMNX
· Real-Time Price · USD
36.99
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Luminex Revenue Breakdown
Period Ending | Dec 31, 2013 | Dec 31, 2012 |
---|---|---|
Assays and Related Products Revenue | 81.4M | 81.55M |
Assays and Related Products Revenue Growth | -0.18% | n/a |
Technology and Strategic Partnerships Revenue | 132.02M | 121.03M |
Technology and Strategic Partnerships Revenue Growth | +9.08% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 39.1M | 40.15M | 37.78M | 37.04M | 36.79M | 33.95M | 34.3M | 36M | 34.34M | 34.2M | 28.51M | 29.78M | 28M | 30.88M | 28.62M | 30.32M | 26.35M | 30.99M | 28.88M | 25.88M | 21.99M | 24.46M | 22.01M | 21.8M | 20.38M |
Selling, General, and Administrative Revenue Growth | -2.60% | +6.27% | +2.00% | +0.69% | +8.36% | -1.02% | -4.72% | +4.82% | +0.41% | +19.99% | -4.27% | +6.36% | -9.35% | +7.91% | -5.60% | +15.05% | -14.96% | +7.32% | +11.58% | +17.70% | -10.13% | +11.14% | +0.97% | +6.97% | n/a |
Research and Development Revenue | 13.9M | 13.8M | 14.07M | 13.86M | 11.92M | 12.93M | 13.26M | 14.98M | 15.05M | 13.17M | 12M | 11.67M | 10.33M | 10.37M | 10.67M | 12.26M | 12.42M | 13.34M | 12.76M | 11.54M | 11.02M | 10.94M | 10.09M | 11.51M | 10.14M |
Research and Development Revenue Growth | +0.75% | -1.98% | +1.52% | +16.32% | -7.85% | -2.48% | -11.50% | -0.42% | +14.26% | +9.79% | +2.78% | +13.04% | -0.40% | -2.84% | -12.97% | -1.29% | -6.86% | +4.49% | +10.56% | +4.76% | +0.70% | +8.41% | -12.31% | +13.45% | n/a |